Clinical Trial Update: Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with 5-FU/FA plus panitumumab versus 5-FU/FA alone after induction/re-induction in first-line metastatic colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-fluorouracil/folinic acid (5-fluorouracil/folinic acid)
• Panitumumab (panitumumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED